Implant or Graft; Rejection Completed Phase 4 Trials for Belatacept (DB06681)

IndicationStatusPhase
DBCOND0071282 (Implant or Graft; Rejection)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02152345Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant RecipientsTreatment